Jun J. Zhu

28 Zhongzhou Road
Jingjiang, 214500, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 231 publications

Aromaticity-promoted oxygen-centered radical stability in α-hydroxy heterocyclics.

Aromaticity-promoted oxygen-centered radical stability in α-hydroxy heterocyclics.

Journal: Physical chemistry chemical physics : PCCP

Published: July 15, 2026

CD19 CAR-T cell therapy in large B-cell lymphoma: clinical evidence, resistance, toxicity, and precision strategies.

CD19 CAR-T cell therapy in large B-cell lymphoma: clinical evidence, resistance, toxicity, and precision strategies.

Journal: Frontiers in immunology

Published: June 08, 2026

First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical Trial.

First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology

Published: June 04, 2026

Substituent-modulated adaptive aromaticity in NHC-pyrrolyl cations: a combined DFT and machine learning study.

Substituent-modulated adaptive aromaticity in NHC-pyrrolyl cations: a combined DFT and machine learning study.

Journal: Physical chemistry chemical physics : PCCP

Published: May 29, 2026

A novel lipid droplet-related prognostic signature reveals CIDEC as a key biomarker for pancreatic adenocarcinoma.

A novel lipid droplet-related prognostic signature reveals CIDEC as a key biomarker for pancreatic adenocarcinoma.

Journal: Frontiers in oncology

Published: April 01, 2026

Long-Term Outcomes of Concurrent Chemoradiotherapy With S-1 in Older Patients With Esophageal Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Long-Term Outcomes of Concurrent Chemoradiotherapy With S-1 in Older Patients With Esophageal Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Journal: JAMA network open

Published: March 27, 2026

Electron-injection-induced global aromaticity enables stable open-shell nanopillars with intense mid-infrared magnetic circular dichroism.

Electron-injection-induced global aromaticity enables stable open-shell nanopillars with intense mid-infrared magnetic circular dichroism.

Journal: Chemical science

Published: March 03, 2026

Liver resection is associated with better survival than TACE for hepatocellular carcinoma modestly beyond Milan criteria: a multicenter propensity-matched analysis.

Liver resection is associated with better survival than TACE for hepatocellular carcinoma modestly beyond Milan criteria: a multicenter propensity-matched analysis.

Journal: Frontiers in oncology

Published: February 20, 2026

Poria cocos polysaccharides alleviate colitis via the tryptophan metabolism-AhR-redox axis.

Poria cocos polysaccharides alleviate colitis via the tryptophan metabolism-AhR-redox axis.

Journal: Journal of ethnopharmacology

Published: February 15, 2026

HLX07, a novel anti-EGFR antibody, for locally advanced and metastatic cutaneous squamous cell carcinoma: an open-label, multicenter, phase II trial.

HLX07, a novel anti-EGFR antibody, for locally advanced and metastatic cutaneous squamous cell carcinoma: an open-label, multicenter, phase II trial.

Journal: Therapeutic advances in medical oncology

Published: January 28, 2026

Probing the longest λmax of azo compounds in near infrared absorption via integrating protonation, antiaromaticity and substituents: a combined DFT and machine learning study.

Probing the longest λmax of azo compounds in near infrared absorption via integrating protonation, antiaromaticity and substituents: a combined DFT and machine learning study.

Journal: Physical chemistry chemical physics : PCCP

Published: January 28, 2026

Serplulimab Plus Chemotherapy, with or without HLX04, versus Chemotherapy as First-Line Treatment for Nonsquamous NSCLC: Final Survival Analysis of the Phase III ASTRUM-002 Study.

Serplulimab Plus Chemotherapy, with or without HLX04, versus Chemotherapy as First-Line Treatment for Nonsquamous NSCLC: Final Survival Analysis of the Phase III ASTRUM-002 Study.

Journal: Cancer communications (London, England)

Published: January 08, 2026

Showing 1-12 of 231

Last Updated: 09/26/2026